DEVELOPMENT OF TRANSMYOCARDIAL LASER REVASCULARIZATION IN PATIENTS WITH ISCHEMIC HEART DISEASE

Cover Page


Cite item

Full Text

Abstract

The use of laser radiation in cardiac surgery allows to provide more effective and targeted care for patients with ischemic heart disease. The article summarizes the multistage teamwork of several research centers in Tomsk on determination of the most effective type of laser and techniques of cardiac surgery using lasers. The study had an experimental and a clinical phase. In the experimental phase, effectiveness of various laser types for indirect laser myocardial revascularization was assessed, including carbon dioxide, neodymium, and a semiconductor laser types. During clinical phase, efficacy of clinical use of semiconductor laser in various timepoints after surgery was evaluated. The experimental phase revealed that semiconductor laser provides the best neoangiogenesis efficiency, minimal myocardial damage and ease of use. During clinical phase, its safety for a patient was established and a significant clinical benefit was observed.

About the authors

V. M. Shipulin

Research Institute for Сardiology

Email: fake@neicon.ru

MD, PhD, Professor, Honoured Science Worker of the Russian Federation, Head of the Department of Сardiovascular Surgery

Россия

S. L. Andreev

Research Institute for Сardiology

Author for correspondence.
Email: anselen@rambler.ru

PhD, Senior Research Fellow, Department of Сardiovascular Surgery

Россия

I. V. Sukhodolo

Siberian State Medical University

Email: fake@neicon.ru

MD, PhD, Professor, Head of the Department of Morphology and General Pathology

Россия

E. P. Gordov

Institute of Monitoring of Climatic and Ecological Systems of the Siberian Branch of the Russian Academy of Sciences

Email: fake@neicon.ru

Doctor of Physics and Mathematics, PhD, Professor, Head of the International Development Research Centre Climate Environmental Studies, Chief Research Fellow

Россия

V. E. Babokin

Moscow Regional Research and Clinical Institute (MONIKI)

Email: fake@neicon.ru

PhD, Head of the Cardiac Surgery Department

Россия

References

  1. Horvath KA, Cohn LH, Cooley DA, Crew JR, Frazier OH, Griffith BP, Kadipasaoglu K, Lansing A, Mannting F, March R, Mirhoseini MR, Smith C. Transmyocardial laser revascularization: results of a multicenter trial with transmyocardial laser revascularization used as sole therapy for end-stage coronary artery disease. J Thorac Cardiovasc Surg. 1997;113(4):645–53.
  2. Mirhoseini M, Shelgikar S, Cayton MM. New concepts in revascularization of the myocardium. Ann Thorac Surg. 1988;45(4):415–20.
  3. Diegeler A. Clinical outcomes after TMR with the Holmium: YAG laser. Presented at: TMR. The Holmium: YAG laser. Clinical outcomes and comparative studies. Prague; 1996.
  4. Frazier OH, March RJ, Horvath KA. Transmyocardial revascularization with a carbon dioxide laser in patients with end-stage coronary artery disease. N Engl J Med. 1999;341(14):1021–8.
  5. Allen GS. Mid-term results after thoracoscopic transmyocardial laser revascularization. Ann Thorac Surg. 2005;80(2):553–8.
  6. Шипулин ВМ, Андреев СЛ, Павлюкова ЕН. Использование лазеров в сердечно-сосудистой хирургии: от эксперимента к практике. Томск: STT; 2010. 238 с. Shipulin VM, Andreev SL, Pavlyukova EN. Ispol'zovanie lazerov v serdechno-sosudistoy khirurgii: ot eksperimenta k praktike [The use of lasers in cardiovascular surgery: from an experiment to practice]. Tomsk: STT; 2010. 238 p. (in Russian).
  7. Гапонцев ВП, Минаев ВП, Пантелеев АМ, Пинский ЮА, Самарцев ИЭ. Портативный лазерный скальпель-коагулятор «Лазон-10-П». Бюллетень физиологии и патологии дыхания. 2001;10:71–2. Gapontsev VP, Minaev VP, Panteleev AM, Pinskiy YuA, Samartsev IE. Portativnyy lazernyy skal'pel'-koagulyator “Lazon-10-P” [A portable laser scalpel-coagulator “Lazon-10-P”]. Byulleten' fiziologii i patologii dykhaniya [Bulletin Physiology and Pathology of Respiration]. 2001;10:71–2 (in Russian).
  8. Шипулин ВМ, Коровин НВ, Павлюкова ЕН, Суходоло ИВ, Андреев СЛ. Первый опыт клинического применения полупроводникового лазера с длиной волны излучения 0,97 мкм для непрямой реваскуляризации миокарда. Лазерная медицина. 2005;9(3):55–6. Shipulin VM, Korovin NV, Pavlyukova EN, Sukhodolo IV, Andreev SL. Pervyy opyt klinicheskogo primeneniya poluprovodnikovogo lazera s dlinoy volny izlucheniya 0,97 mkm dlya nepryamoy revaskulyarizatsii miokarda [The first clinical experience of the application of semiconductor laser with wavelength 0.97-mm for indirect myocardium revascularization]. Lazernaya meditsina [Laser medicine]. 2005;9(3):55–6 (in Russian).

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2015 Shipulin V.M., Andreev S.L., Sukhodolo I.V., Gordov E.P., Babokin V.E.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies